← All trials
NCT01374971
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2011
- Primary completion
- Jul 1, 2012
- Completion date
- Jul 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 12
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Arthritis Treatment Center, MarylandLead sponsor
- Arthritis Treatment Center, Frederick, MarylandOverall official - principal investigator
- Arthritis Treatment Center, Frederick, MarylandSponsor investigator
- University of California, San DiegoCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.